CN101508689A - Synthesis of oroxylin - Google Patents
Synthesis of oroxylin Download PDFInfo
- Publication number
- CN101508689A CN101508689A CNA2009100298679A CN200910029867A CN101508689A CN 101508689 A CN101508689 A CN 101508689A CN A2009100298679 A CNA2009100298679 A CN A2009100298679A CN 200910029867 A CN200910029867 A CN 200910029867A CN 101508689 A CN101508689 A CN 101508689A
- Authority
- CN
- China
- Prior art keywords
- benzyl
- synthetic method
- oroxylin
- dihydroxyflavone
- methoxyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the chemical synthesis field, in particular to a synthetic method of traditional Chinese herbal skullcap momoner oroxylin. The method is characterized by comprising the following steps: 5,6,7-trihydroxyflavone, benzyl bromide and benzyl chloride are subject to nucleophilic substitution reaction in the presence of an acid coating agent to generate 7-benzyl-5,6-dihydroxyflavone, the generated 7-benzyl-5,6-dihydroxyflavone reacts with dimethyl sulfate in the presence of the acid coating agent to generate 7-benzyl-6-methoxyl-5-hydroxylflavone; and the 7-benzyl-6-methoxyl-5-hydroxylflavone is subject to debenzylation in the presence of palladium-carbon under the reducing action of catalytic hydrogenation to obtain the oroxylin. The method has the advantages of simple steps, mild conditions, more than 65% of total reaction yield and high synthetic product purity of more than 99.0%.
Description
Technical field
The present invention relates to the field of chemical synthesis, particularly, the present invention relates to the synthetic of baikal skullcap root monomer oroxylin.
Background technology
Oroxylin is a contained chromocor compound in the labiate root of large-flowered skullcap (the Scutellaria baicalensis Georgi) root, has the structure of formula (I).
Formula (I)
Studies show that oroxylin has multiple pharmacological effect, comprise the memory impairment, mediation hepatoma cell line HepG2 apoptosis, the anti-inflammatory that improve eastern scopola alkali and big cerebral blood perfusion mediation, protect the liver and suppress effects such as sleep.
Because oroxylin has pharmacologically active widely, and extraction process is loaded down with trivial details from plant, purity is low, the cost height, and people explore its total synthesis method.
The method of complete synthesis oroxylin mainly contains following five kinds
(1) Allan-Robinson condensation method (Murti, V.V.Sreerama; Seshadri, T.R.Proceedings-Indian Academy of Sciences, Section A (1949), 29A1-8.) this method is with 2,4, and the 6-trihydroxy-acetophenone is a raw material, through part benzylization, part methylization, K
2S
2O
8Oxidation obtains 2, and 5-dihydroxyl-4 benzyloxies-6-methoxyacetophenone is then at Bz
2The Allan-Robinson condensation takes place down and obtains 7-benzyloxy-5-methoxy flavone in O and BzONa effect, and again through methylating, debenzylation and part demethylation obtain oroxylin under the HBr effect.This method technology is loaded down with trivial details, and yield is low, no practical value.
(2) with the scutellarin be synthetic method (Sarin, the P.S. of intermediate; Seshadri, T.R.Journal ofScientific ﹠amp; Industrial Research 1960), 19B117.) this method is raw material with the scutellarin, through the selectivity benzylization, and part methylization, debenzylation can obtain oroxylin.Document reports that in selectivity benzyl step yield is lower in this method.
(3) with 3,4,5-trimethoxy phenol is synthetic method (Shaw, the Jiajiu of raw material; Lee, An-Rong; Huang, Wen-Hsin.US 2004242907) this method second 3,4,5-trimethoxy phenol is raw material, through the Fries reaction, and dioxide giving, the part demethylation obtains oroxylin.
(4) pyrocondensation method (Rivaille, Pierre; Mentzner, Charles.Compt.Rend. (1965), 260 (8), 2243-5.) this method is with 2, the 6-2-methoxyhydroquinone for raw material directly and ethyl benzoylacetate condensation at high temperature obtain oroxylin.This method selectivity when pyrocondensation is bad, produces a large amount of methyl wogonins.
(5) isomerization method (Jozaef Varady Tetrahedron Letters; 196548; 4281-4282) this method is raw material with the wogonin; the part benzylization obtains 7-benzyl wogonin; isomerization reaction takes place under benzylalcohol and salt of wormwood effect then obtain 7-benzyl oroxylin, last debenzylation protection obtains oroxylin.The raw material wogonin that uses in this method needs polystep reaction synthetic, and the cost height only is fit to research and uses, and is not suitable for a large amount of synthetic oroxylins.
Summary of the invention
The invention discloses a kind of synthetic method of oroxylin, the present invention is the synthetic oroxylin of intermediate with the scutellarin, simple synthetic method, yield height, product purity height.
Synthetic method of the present invention is following reaction formula:
Comprise the following steps: successively
A. with 5 (compound 2) in the presence of acid-binding agent with cylite Benzyl Chloride generation nucleophilic substitution reaction, generate 7-benzyl-5,6-dihydroxyflavone (compound 3);
B. the compound 3 with above-mentioned generation reacts with methyl-sulfate in the presence of acid-binding agent, generates 7-benzyl-6-methoxyl group-5-flavonol (compound 4);
C. above-claimed cpd 4 debenzylation under the reductive action of catalytic hydrogenation in the presence of the palladium carbon is obtained oroxylin (compound 1).
Above-mentioned reaction a or b step are preferably reacted in following one or more organic solvent: acetone, DMF (N, dinethylformamide), acetonitrile, ethanol, chloroform, ethyl acetate.Further preferred acetone or alcohol.
The preferred yellow soda ash of acid-binding agent, salt of wormwood, saleratus or sodium bicarbonate.
Preferably in the reaction solvent of tetrahydrofuran (THF), ethanol, methyl alcohol, acetone, ethyl acetate or DMF, react in the c step.
In the above-mentioned reaction, preferred 10 ℃~150 ℃ of the temperature of reaction of a step or b step.Further preferred 30 ℃~60 ℃.
Preferred protective gas nitrogen or the argon gas of feeding in step a, b and the c reaction system.
Preferred 1:1~the 1:3 of mol ratio of 5 and cylite or Benzyl Chloride in a step wherein.Further preferred 1:1.4.
7-benzyl-5 in the b step, the preferred 1:4~1:10 of the mol ratio of 6-dihydroxyflavone and methyl-sulfate.Further preferred 1:6.6.
Preferred 1:0.05~the 1:1 of weight ratio of 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones and palladium carbon in the c step.Further preferred 1:0.1.
Step of the present invention is simple, and mild condition, overall yield of reaction are greater than 65%, and synthetic product purity height is greater than 99.0%.
Embodiment
Embodiment 1
7-benzyl-5, the preparation of 6-dihydroxyflavone
Mechanical stirrer, thermometer are being housed, are adding scutellarin 16g in the 2000ml reaction flask of nitrogen ingress pipe, acetone 1600mL feeds N
2Displaced air keeps logical nitrogen, is heated to 32 ℃, and scutellarin is dissolved fully, adds K
2CO
359g, cylite 10mL, reaction 48h, cooling is evaporated to driedly, adds 200 ml waters and stirs, and filters, dry yellow solid 15.5g, yield 92%, Mp:195 ℃-196 ℃.10%FeCl
3It is blackish green that ethanolic soln shows
1H-NMR(DMSO-d
6,300Hz):δ?5.30(2H,s,CH
2Ph),7.01(1H,s,3H),7.12(1H,S,8H)7.33-7.65(10H,m,ArH),8.08-8.10(2H,d,ArH),8.83(1H,s,6-OH),12.55(1H,s,5-OH)MS(EI,m/z)360,269,241,139,91
Embodiment 2
7-benzyloxy-5, the preparation of 6-dihydroxyflavone
Mechanical stirrer, thermometer are being housed, are adding scutellarin 16g (59mmol) in the 2000ml reaction flask of nitrogen ingress pipe, ethanol 1500mL feeds N
2Displaced air keeps logical nitrogen, is heated to 40 ℃, and scutellarin is dissolved fully, adds Na
2CO
355g, cylite 15mL, reaction 24h, cooling is evaporated to driedly, adds 200 ml waters and stirs, and filters, dry yellow solid 14.0g, yield 77%, Mp:195 ℃-196 ℃.10%FeCl
3It is blackish green that ethanolic soln shows.
Embodiment 3
7-benzyloxy-5, the preparation of 6-dihydroxyflavone
Mechanical stirrer, thermometer are being housed, are adding scutellarin 16g (59mmol) in the 2000ml reaction flask of nitrogen ingress pipe, acetone 1500mL feeds N
2Displaced air is heated to 40 ℃, and scutellarin is dissolved fully, adds KHCO
359g, cylite 15mL, reaction 24h, cooling is evaporated to driedly, adds 200 ml waters and stirs, and filters, dry yellow solid 13.0g, yield 82%, Mp:195 ℃-196 ℃.10%FeCl
3It is blackish green that ethanolic soln shows.
Embodiment 4
The preparation of 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones
Mechanical stirring, thermometer are being housed, are adding 7-benzyl-5 in the 2000ml reaction flask of nitrogen ingress pipe, 6-dihydroxyflavone 8g (22mmol), ethanol 1600mL feeds N
2Displaced air adds anhydrous K
2CO
330g (0.22mol), methyl-sulfate 16mL finishes back flow reaction 6h, and TLC detects no raw material point, and cooling is evaporated to driedly, adds 100 ml waters and stirs, and filters, dry yellow solid 8g, yield 96%.Mp:165-166℃。
1HNMR(CDCl
3,300Hz):δ?3.95(3H,s,OCH
3),5.25(2H,s,CH
2Ph),7.31-7.88(10H,m,Ar-H),7.86-7.88(2H,d,Ar-H),12.70(1H,s,5-OH)
MS(EI,m/z)374,359,283,153,91
Embodiment 5
The preparation of 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones
Mechanical stirring, thermometer are being housed, are adding 7-benzyl-5 in the 2000ml reaction flask of nitrogen ingress pipe, 6-dihydroxyflavone 8g (22mmol), acetone 1500mL feeds N
2Displaced air adds anhydrous Na
2CO
328g, methyl-sulfate 25mL finishes back flow reaction 6h, and cooling is filtered, and filtrate decompression reclaims, and cooling is evaporated to driedly, adds 200 ml waters and stirs, and filters, dry yellow solid 7.2g, yield 87%.Mp:165-166℃。
Embodiment 6
The preparation of oroxylin
In being housed, the 1000mL single port bottle of magnetic agitation adds 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones 8g (21mmol), 10% Pd/C 0.8g, tetrahydrofuran (THF) 500ml, reacted 5 hours, reaction is finished, and filters, and decompression and solvent recovery is to doing, re-crystallizing in ethyl acetate can get the oroxylin 4.5g of purity 99%.Yield 74%Mp:198 ℃-199 ℃ (195 ℃-197 ℃ in document)
1HNMR (DMSO-d
6, 300Hz): δ 3.85 (3H, s, OCH
3), 6.63 (1H, s, 3H), 6.95 (1H, S, 8H), 7.56-7.59 (3H, m, ArH), 8.05-8.07 (2H, d, ArH), 10.78 (1H, s, 7-OH), 12.92 (1H, s, 5-OH) MS (EI, m/z), 284,269,241,139
IR?1653cm
-1(v
C=O),3455cm
-1(voH)。
Claims (10)
1, a kind of synthetic method of oroxylin comprises the following steps: successively
A, with 5 in the presence of acid-binding agent with cylite or Benzyl Chloride generation nucleophilic substitution reaction, generate 7-benzyl-5, the 6-dihydroxyflavone;
B, with 7-benzyl-5, the 6-dihydroxyflavone in the presence of acid-binding agent with methyl-sulfate reaction, generate 7-benzyl-6-methoxyl group-5-flavonol;
C, 7-benzyl-6-methoxyl group-5-flavonol catalytic hydrogenation debenzylation in the presence of palladium carbon is obtained oroxylin.
2, the synthetic method of claim 1, wherein a or b step reaction solvent are selected from one or more in acetone, N.N-dimethyl formamide, acetonitrile, ethanol, chloroform, the ethyl acetate.
3, the synthetic method of claim 2, wherein a or b step reaction solvent are acetone or alcohols.
4, the synthetic method of claim 1, wherein acid-binding agent is salt of wormwood, saleratus, sodium bicarbonate or yellow soda ash.
5, the synthetic method of claim 1, wherein c step reaction solvent is selected from tetrahydrofuran (THF), ethanol, methyl alcohol, ethyl acetate or N.N-dimethyl formamide.
6, the synthetic method of claim 1, wherein a or b step reaction temperature are 10 ℃~150 ℃.
7, the synthetic method of claim 6, wherein a or b step reaction temperature are 30 ℃~60 ℃.
8, the synthetic method of claim 1 wherein feeds nitrogen or argon gas in a, b or the c step reaction.
9, the synthetic method of claim 1, wherein the mol ratio of 5 and cylite or Benzyl Chloride is 1:1~1:3 in a step; 7-benzyl-5 in the b step, the mol ratio of 6-dihydroxyflavone and methyl-sulfate are 1:4~1:10; The weight ratio of 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones and palladium carbon is 1:0.05~1:1 in the c step.
10, the synthetic method of claim 9, wherein the mol ratio of 5 and cylite or Benzyl Chloride is 1:1.4 in a step; 7-benzyl-5 in the b step, the mol ratio of 6-dihydroxyflavone and methyl-sulfate are 1:6.6; The weight ratio of 5-hydroxyl-6-methoxyl group-7-benzyloxy flavones and palladium carbon is 1:0.1 in the c step.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100298679A CN101508689B (en) | 2009-03-26 | 2009-03-26 | Synthesis of oroxylin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100298679A CN101508689B (en) | 2009-03-26 | 2009-03-26 | Synthesis of oroxylin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101508689A true CN101508689A (en) | 2009-08-19 |
CN101508689B CN101508689B (en) | 2010-12-08 |
Family
ID=41001238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100298679A Active CN101508689B (en) | 2009-03-26 | 2009-03-26 | Synthesis of oroxylin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101508689B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101948458A (en) * | 2010-09-07 | 2011-01-19 | 中国药科大学 | Baicalein derivatives with antitumor activity and application thereof in medicines |
CN103193747A (en) * | 2013-04-18 | 2013-07-10 | 中国药科大学 | Method for preparing fesoterodine fumarate intermediate |
CN103211810A (en) * | 2013-03-29 | 2013-07-24 | 广东医学院附属医院 | Application of Oroxylin A |
CN104387360A (en) * | 2014-11-21 | 2015-03-04 | 段煜 | Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition |
CN108456190A (en) * | 2017-02-22 | 2018-08-28 | 嘉药学校财团法人嘉南药理大学 | The synthetic method of qroxylin A |
WO2020032913A1 (en) * | 2018-08-04 | 2020-02-13 | Muhammed Majeed | Process for synthesis of oroxylin a |
CN111100103A (en) * | 2018-10-26 | 2020-05-05 | 北京恩成康泰生物科技有限公司 | Method for synthesizing oroxylin |
CN116162077A (en) * | 2023-02-28 | 2023-05-26 | 苏州普瑞森生物科技有限公司 | Baicalein derivative and preparation method and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI637947B (en) * | 2017-02-14 | 2018-10-11 | 嘉藥學校財團法人嘉南藥理大學 | Synthetic method of Melaleuca A |
-
2009
- 2009-03-26 CN CN2009100298679A patent/CN101508689B/en active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101948458A (en) * | 2010-09-07 | 2011-01-19 | 中国药科大学 | Baicalein derivatives with antitumor activity and application thereof in medicines |
CN101948458B (en) * | 2010-09-07 | 2012-11-07 | 中国药科大学 | Baicalein derivatives with antitumor activity and application thereof in medicines |
CN103211810A (en) * | 2013-03-29 | 2013-07-24 | 广东医学院附属医院 | Application of Oroxylin A |
CN103193747A (en) * | 2013-04-18 | 2013-07-10 | 中国药科大学 | Method for preparing fesoterodine fumarate intermediate |
CN104387360A (en) * | 2014-11-21 | 2015-03-04 | 段煜 | Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition |
CN108456190A (en) * | 2017-02-22 | 2018-08-28 | 嘉药学校财团法人嘉南药理大学 | The synthetic method of qroxylin A |
CN108456190B (en) * | 2017-02-22 | 2020-09-22 | 嘉药学校财团法人嘉南药理大学 | Method for synthesizing oroxylin A |
WO2020032913A1 (en) * | 2018-08-04 | 2020-02-13 | Muhammed Majeed | Process for synthesis of oroxylin a |
CN111100103A (en) * | 2018-10-26 | 2020-05-05 | 北京恩成康泰生物科技有限公司 | Method for synthesizing oroxylin |
CN116162077A (en) * | 2023-02-28 | 2023-05-26 | 苏州普瑞森生物科技有限公司 | Baicalein derivative and preparation method and application thereof |
CN116162077B (en) * | 2023-02-28 | 2024-02-02 | 苏州普瑞森生物科技有限公司 | Baicalein derivative and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101508689B (en) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101508689B (en) | Synthesis of oroxylin | |
CN102584795B (en) | Preparing method of crizotinib | |
CN105237503B (en) | A kind of method for preparing baicalein | |
CN101967140A (en) | Deuterated crizotinib as well as derivant, preparation method and application thereof | |
CN101875680A (en) | Nucleoside compound, preparation method and application thereof | |
CN102659726A (en) | Method for synthesis of dronedarone | |
CN101735190A (en) | Method for preparing baicalein | |
CN109422788B (en) | Preparation method of cytarabine hydrochloride | |
CN103374050A (en) | Method for preparing 5,6,4'-trihydroxy flavone-7-0-D-glucuronic acid | |
CN102850377B (en) | Preparation method of levofloxacin hydrochloride | |
CN102408401B (en) | Synthesis method of Cochinchinenin B | |
CN104311518A (en) | Preparation method for 6-methoxyscutellarin | |
CN103965151A (en) | Preparation and antineoplastic test application of novel kaempferol derivatives | |
CN103254191B (en) | Substituted aroma four lopps antifungal compound and preparation method thereof and application | |
CN101195602B (en) | 1-deoxidization nojiri toxin derivant, production method and uses thereof | |
CN103374049B (en) | One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid | |
CN101148448A (en) | N2Process for preparing -quinoline substituted purine derivatives | |
CN101003530B (en) | Method for preparing perfluoroalkyl group sulfonyl isoflavone of possessing anticarcinogenesis | |
CN101792451A (en) | Full synthesis method of 4'',5''-dihydroxyl-5-methoxyl-[6'',6''-dimethyl pyran (2'',3'':7,8)] Hirtellanine A | |
CN116768839A (en) | Synthesis method of oroxylin | |
CN102127134B (en) | Ribavirin compound and novel preparation method thereof | |
CN103936704A (en) | Method of preparing chrysin | |
CN103254054B (en) | Compound with cancer prevention effect and preparation method thereof | |
CN114213483B (en) | Preparation method of marine flavone glycoside | |
CN113387804B (en) | Synthesis method of alpha-asarone acetate and alpha-octanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211011 Address after: Room 303, building B, phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1, xinjinhu Road, Jiangbei new area, Nanjing, Jiangsu 210031 Patentee after: Nanjing Qinling Pharmaceutical Technology Co.,Ltd. Address before: Nanjing City, Jiangsu Province, Tong Lane 210009 No. 24 Patentee before: CHINA PHARMACEUTICAL University |
|
TR01 | Transfer of patent right |